
Genesis Molecular AIrevenue
Pharma and Biotech SoftwareBurlingame, CaliforniaCEO Evan Feinberg
Genesis Molecular AI – headquartered in Burlingame, CA, with a fully integrated laboratory in San Diego and offices in New York – is pioneering foundation models for molecular AI to unlock a new era of drug design and development.
Genesis Molecular AI revenue
Genesis Molecular AI has not published its revenue. GetLatka estimates it at about $16.1M a year (November 2025).
| As of | Revenue | Source |
|---|---|---|
| Nov 2025 | $16.1MEST | GetLatka estimate |
Genesis Molecular AI competitors
Genesis Molecular AI competes most directly with insitro and Recursion.
Genesis Molecular AI CEO, founders & employees
Evan Feinberg founded Genesis Molecular AI and runs it as CEO. Genesis Molecular AI has 146 employees (November 2025, LinkedIn).
- Evan FeinbergCEO/Founder
Genesis Molecular AI FAQ
What is Genesis Molecular AI's revenue?
GetLatka estimates Genesis Molecular AI's revenue at about $16.1M a year (November 2025). The company hasn't published its own figure.
How many employees does Genesis Molecular AI have?
Genesis Molecular AI has 146 employees as of November 2025, according to LinkedIn.
Who is the CEO of Genesis Molecular AI?
Evan Feinberg is the CEO of Genesis Molecular AI and founded the company.
Who founded Genesis Molecular AI?
Evan Feinberg founded Genesis Molecular AI.
Browse Pharma and Biotech Software
How this page is sourced
1 from public sources · 1 estimate. Founder figures link to the second they were said; public figures name their source; estimates are marked EST and say whose they are. Not financial advice.
Updated Sep 15, 2026Data disclaimerReport a correctionClaim this profileRun Genesis Molecular AI? Join the podcast